549 related articles for article (PubMed ID: 12412029)
61. Localized proton magnetic resonance spectroscopy of the cerebellum in detoxifying alcoholics.
Seitz D; Widmann U; Seeger U; Nägele T; Klose U; Mann K; Grodd W
Alcohol Clin Exp Res; 1999 Jan; 23(1):158-63. PubMed ID: 10029218
[TBL] [Abstract][Full Text] [Related]
62. Temporal window of metabolic brain vulnerability to concussion: a pilot 1H-magnetic resonance spectroscopic study in concussed athletes--part III.
Vagnozzi R; Signoretti S; Tavazzi B; Floris R; Ludovici A; Marziali S; Tarascio G; Amorini AM; Di Pietro V; Delfini R; Lazzarino G
Neurosurgery; 2008 Jun; 62(6):1286-95; discussion 1295-6. PubMed ID: 18824995
[TBL] [Abstract][Full Text] [Related]
63. Pitfalls and advantages of different strategies for the absolute quantification of N-acetyl aspartate, creatine and choline in white and grey matter by 1H-MRS.
Malucelli E; Manners DN; Testa C; Tonon C; Lodi R; Barbiroli B; Iotti S
NMR Biomed; 2009 Dec; 22(10):1003-13. PubMed ID: 19504521
[TBL] [Abstract][Full Text] [Related]
64. Automated quantification of human brain metabolites by artificial neural network analysis from in vivo single-voxel 1H NMR spectra.
Kaartinen J; Mierisová S; Oja JM; Usenius JP; Kauppinen RA; Hiltunen Y
J Magn Reson; 1998 Sep; 134(1):176-9. PubMed ID: 9740747
[TBL] [Abstract][Full Text] [Related]
65. Antiretroviral therapy and its influence on the stage of brain damage in patients with HIV - 1H MRS evaluation.
Tarasów E; Wiercińska-Drapało A; Jaroszewicz J; Orzechowska-Bobkiewicz A; Dzienis W; Prokopowicz D; Walecki J
Med Sci Monit; 2004 Jun; 10 Suppl 3():101-6. PubMed ID: 16538209
[TBL] [Abstract][Full Text] [Related]
66. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
[TBL] [Abstract][Full Text] [Related]
67. Improved reproducibility of MRS regional brain thermometry by 'amplitude-weighted combination'.
Cady EB; Penrice J; Robertson NJ
NMR Biomed; 2011 Aug; 24(7):865-72. PubMed ID: 21834009
[TBL] [Abstract][Full Text] [Related]
68. Relaxation times of choline, creatine and N-acetyl aspartate in human cerebral white matter at 1.5 T.
Rutgers DR; van der Grond J
NMR Biomed; 2002 May; 15(3):215-21. PubMed ID: 11968137
[TBL] [Abstract][Full Text] [Related]
69. Quantification of human brain metabolites from in vivo 1H NMR magnitude spectra using automated artificial neural network analysis.
Hiltunen Y; Kaartinen J; Pulkkinen J; Häkkinen AM; Lundbom N; Kauppinen RA
J Magn Reson; 2002 Jan; 154(1):1-5. PubMed ID: 11820820
[TBL] [Abstract][Full Text] [Related]
70. Localised 1H-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV.
Simone IL; Federico F; Tortorella C; Andreula CF; Zimatore GB; Giannini P; Angarano G; Lucivero V; Picciola P; Carrara D; Bellacosa A; Livrea P
J Neurol Neurosurg Psychiatry; 1998 Apr; 64(4):516-23. PubMed ID: 9576546
[TBL] [Abstract][Full Text] [Related]
71. Magnetic resonance spectroscopy of the cerebellum in patients with spinocerebellar ataxia type 3/Machado-Joseph disease.
Lei L; Liao Y; Liao W; Zhou J; Yuan Y; Wang J; Jiang H; Shen L; Tang B
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2011 Jun; 36(6):511-9. PubMed ID: 21743142
[TBL] [Abstract][Full Text] [Related]
72. [Brain metabolic disorders after chemotherapy in the study by magnetic resonance spectroscopy].
Ciszkowska-Łysoń B; Królicki L; Teska A; Janowicz-Zebrowska A; Krzakowski M; Tacikowska M
Neurol Neurochir Pol; 2003; 37(4):783-98. PubMed ID: 14746239
[TBL] [Abstract][Full Text] [Related]
73. Comparison of 1.5T and 3T 1H MR spectroscopy for human brain tumors.
Kim JH; Chang KH; Na DG; Song IC; Kim SJ; Kwon BJ; Han MH
Korean J Radiol; 2006; 7(3):156-61. PubMed ID: 16969044
[TBL] [Abstract][Full Text] [Related]
74. Cerebral metabolites in patients with acute and subacute strokes: concentrations determined by quantitative proton MR spectroscopy.
Mathews VP; Barker PB; Blackband SJ; Chatham JC; Bryan RN
AJR Am J Roentgenol; 1995 Sep; 165(3):633-8. PubMed ID: 7645484
[TBL] [Abstract][Full Text] [Related]
75. Occipital proton magnetic resonance spectroscopy (1H-MRS) reveals normal metabolite concentrations in retinal visual field defects.
Boucard CC; Hoogduin JM; van der Grond J; Cornelissen FW
PLoS One; 2007 Feb; 2(2):e222. PubMed ID: 17311099
[TBL] [Abstract][Full Text] [Related]
76. Cerebral metabolic alterations in human immunodeficiency virus-related encephalopathy detected by proton magnetic resonance spectroscopy. Comparison between sequences using short and long echo times.
Salvan AM; Vion-Dury J; Confort-Gouny S; Nicoli F; Lamoureux S; Cozzone PJ
Invest Radiol; 1997 Aug; 32(8):485-95. PubMed ID: 9258737
[TBL] [Abstract][Full Text] [Related]
77. Relative metabolite concentrations and ratios determined by use of 3-T region-specific proton magnetic resonance spectroscopy of the brain of healthy Beagles.
Warrington CD; Feeney DA; Ober CP; Jessen CR; Steward SM; Armién AG; Fletcher TF
Am J Vet Res; 2013 Oct; 74(10):1291-303. PubMed ID: 24066913
[TBL] [Abstract][Full Text] [Related]
78. Age dependence of regional proton metabolites T2 relaxation times in the human brain at 3 T.
Kirov II; Fleysher L; Fleysher R; Patil V; Liu S; Gonen O
Magn Reson Med; 2008 Oct; 60(4):790-5. PubMed ID: 18816831
[TBL] [Abstract][Full Text] [Related]
79. Proton MR spectroscopy in neonates with perinatal cerebral hypoxic-ischemic injury: metabolite peak-area ratios, relaxation times, and absolute concentrations.
Cheong JL; Cady EB; Penrice J; Wyatt JS; Cox IJ; Robertson NJ
AJNR Am J Neuroradiol; 2006 Aug; 27(7):1546-54. PubMed ID: 16908578
[TBL] [Abstract][Full Text] [Related]
80. Serial precision of metabolite peak area ratios and water referenced metabolite peak areas in proton MR spectroscopy of the human brain.
Simmons A; Smail M; Moore E; Williams SC
Magn Reson Imaging; 1998 Apr; 16(3):319-30. PubMed ID: 9621973
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
